Pulmonary hemodynamics and blood flow characteristics in chronic pulmonary hypertension

被引:16
作者
Chen, EP [1 ]
Bittner, HB [1 ]
Craig, DM [1 ]
Davis, RD [1 ]
VanTrigt, P [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DIV THORAC & CARDIOVASC SURG,DURHAM,NC 27710
关键词
D O I
10.1016/S0003-4975(96)01258-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Lung transplantation is now an acceptable form of therapy for pulmonary hypertension, but controversy remains regarding the most appropriate surgical procedure. In this study, the changes in pulmonary vascular mechanics occurring in the setting of pulmonary hypertension were investigated using an adult canine model of monocrotaline pyrrole-induced pulmonary hypertension. Methods. Animals underwent pulmonary artery catheterization to measure right heart pressures before and 8 weeks after injection of either 3 mg/kg of monocrotaline pyrrole (n = 8) or placebo (n = 8). Eight weeks after injection, hearts underwent instrumentation with an ultrasonic flow probe and micromanometers. Harmonic derivation of functional data was achieved with Fourier analysis. Results. Significant increases in mean pulmonary artery pressure and pulmonary vascular resistance were observed after monocrotaline pyrrole injection. There was no significant difference in pulmonary blood flow. However, significant increases in input resistance and right ventricular hydraulic power with significant decreases in transpulmonary efficiency were observed. Conclusions. Pulmonary hypertension causes significant alterations in pulmonary hemodynamics. Pulmonary blood flow is maintained by a significant increase in total power but with a significant decrease in transpulmonary efficiency. This adult canine model of pulmonary hypertension provides a useful means by which to evaluate surgical options of lung transplantation for improving pulmonary hemodynamics in the setting of chronic pulmonary hypertension. (C) 1997 by The Society of Thoracic Surgeons.
引用
收藏
页码:806 / 813
页数:8
相关论文
共 29 条
[21]  
PARQUIN F, 1993, TRANSPLANT P, V25, P1157
[22]   SINGLE-LUNG TRANSPLANTATION FOR PULMONARY-HYPERTENSION - 3-MONTH HEMODYNAMIC FOLLOW-UP [J].
PASQUE, MK ;
TRULOCK, EP ;
KAISER, LR ;
COOPER, JD .
CIRCULATION, 1991, 84 (06) :2275-2279
[23]  
PASQUE MK, 1992, J THORAC CARDIOV SUR, V103, P475
[24]   HEART-LUNG TRANSPLANTATION - SUCCESSFUL THERAPY FOR PATIENTS WITH PULMONARY VASCULAR-DISEASE [J].
REITZ, BA ;
WALLWORK, JL ;
HUNT, SA ;
PENNOCK, JL ;
BILLINGHAM, ME ;
OYER, PE ;
STINSON, EB ;
SHUMWAY, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (10) :557-564
[25]  
ROTH RA, 1991, ADV EXP MED BIOL, V283, P477
[26]   ORAL HYDRALAZINE THERAPY FOR PRIMARY PULMONARY-HYPERTENSION [J].
RUBIN, LJ ;
PETER, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (02) :69-73
[27]   REACTIVE PULMONARY ARTERIAL HYPERTENSION AFTER PULMONARY VENOUS CONSTRICTION IN CALF [J].
SILOVE, ED ;
TAVERNOR, WD ;
BERRY, CL .
CARDIOVASCULAR RESEARCH, 1972, 6 (01) :36-+
[28]   MECHANISMS AND PATHOLOGY OF MONOCROTALINE PULMONARY TOXICITY [J].
WILSON, DW ;
SEGALL, HJ ;
PAN, LC ;
LAME, MW ;
ESTEP, JE ;
MORIN, D .
CRITICAL REVIEWS IN TOXICOLOGY, 1992, 22 (5-6) :307-325
[29]  
Wormersly J. R., 1957, PHYS MED BIOL, V2, P178